DEC 17, 2020 4:00 PM PST

Molecular Mechanism Behind Ketamine for Depression Discovered

WRITTEN BY: Annie Lennon

Over 30% of people with major depressive disorder are resistant to serotonin reuptake inhibitors (SSRI's), the current frontline prescription drug for the condition. Researchers are thus scrambling to find an alternative. Now, researchers from Canada have found that ketamine works against depression via a group of proteins involved in memory formation. Their discovery will go on to create better treatments for some patients with major depression. 

Ketamine was initially approved by the FDA as an anaesthetic in the 1970's. However, research has since found that it is also effective against depression. Unlike standard treatments for the condition, which typically take weeks to have an effect, ketamine works within hours. And now, researchers have uncovered one of the molecular mechanisms behind this effect. 

For their study, they examined the effects of ketamine on behavior and neuronal activity in mice. They used genetic tools to remove 4E-BP proteins (important for switching protein synthesis for memory formation on or off) from excitatory neurons (which make up most of the neurons in certain areas of the brain) and inhibitory neurons (those which control excitatory neurons) to see how ketamine worked in each case. 

In the end, the found that when 4E-BP proteins were absent from both types of neurons, ketamine was unable to relieve depressive behaviors and neuronal patterns. This came as these proteins were able to turn protein synthesis necessary for memory formation on or off. 

"Too many decisions continue to be made by a trial-and-error approach that can prolong the suffering of patients and affect their quality of life," says co-author of the study, Argel Aguilar-Valles. 

"Our discovery has the potential to bring us closer to find a safer alternative to ketamine, and ultimately to a personalized medicine approach, where medical treatments are tailored to the individual characteristics of each patient."

 

Sources: Neuroscience NewsNature

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JAN 13, 2021
Drug Discovery & Development
Could Rotten Egg Gas Reverse Alzheimer's?
JAN 13, 2021
Could Rotten Egg Gas Reverse Alzheimer's?
Researchers from Johns Hopkins University have found that hydrogen sulfide, a gas that smells like rotten eggs, may prot ...
JAN 22, 2021
Drug Discovery & Development
Treating NF1: Investigational Drug Shows Positive Results
JAN 22, 2021
Treating NF1: Investigational Drug Shows Positive Results
From preclinical studies, researchers have found that an investigational drug called ‘cabozantinib’ can trea ...
FEB 11, 2021
Drug Discovery & Development
Antibiotic-Use During Pregnancy
FEB 11, 2021
Antibiotic-Use During Pregnancy
A study published in the Archives of Disease in Childhood, shows that fetal exposure to antibiotics in mid to late pregn ...
FEB 24, 2021
Drug Discovery & Development
How Caffeine Changes the Brain?
FEB 24, 2021
How Caffeine Changes the Brain?
Caffeine is the worlds most consumed psychoactive substance which includes coffee, cola or an energy drink. However, res ...
MAR 20, 2021
Drug Discovery & Development
Weekly Insulin for Type 2 Diabetes Proved Effective
MAR 20, 2021
Weekly Insulin for Type 2 Diabetes Proved Effective
A study found that a new once-weekly basal insulin injection holds similar efficacy, safety and lower rate of low blood ...
MAR 30, 2021
Microbiology
A Marburg Virus Treatment Approach is Identified
MAR 30, 2021
A Marburg Virus Treatment Approach is Identified
Marburg virus causes severe hemorrhagic fever; its fatality ratio can be as high as 88 percent. Researchers may have now ...
Loading Comments...